Who has invested in Asceneuron?

Novo Holdings, EQT Group Life Sciences, OrbiMed, SR One, M Ventures, Sofinnova Partners are named among the investors backing Asceneuron.

Asceneuron Funding: $100M Raised, Series C (2024)

Asceneuron funding overview

Asceneuron is based in Lausanne, Vaud, CH. Asceneuron has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2024. The round record for Asceneuron runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, EQT Group Life Sciences, OrbiMed, SR One, M Ventures, Sofinnova Partners and 2 others. 8 distinct backers are named across the disclosed rounds.

Asceneuron at a glance

Total raised: $100M
Latest round: Series C
Latest round date: July 2024
Headquarters: Lausanne, Vaud, CH
Notable investors: Novo Holdings, EQT Group Life Sciences, OrbiMed, SR One, M Ventures, Sofinnova Partners, GSK Equities Investment Limited, Johnson & Johnson Innovation JJDC Inc.

Frequently asked about Asceneuron funding

How much has Asceneuron raised?: Asceneuron has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Asceneuron?: Novo Holdings, EQT Group Life Sciences, OrbiMed, SR One, M Ventures, Sofinnova Partners are named among the investors backing Asceneuron.
What was the latest Asceneuron funding round?: The most recent disclosed round is a Series C, announced in July 2024.
Where is Asceneuron based?: Asceneuron is based in Lausanne, Vaud, CH.
When did Asceneuron last raise?: The last disclosed Asceneuron round closed in July 2024 at Series C.

Round data for Asceneuron is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Lausanne and backer lists below.

Asceneuron Funding: $100M Raised, Series C (2024)

Asceneuron funding overview

Asceneuron at a glance

Frequently asked about Asceneuron funding

Companies related to Asceneuron (36)

Browse related funding lists (7)